Drug Shortage Report for CODEINE CONTIN 50MG CONTROLLED RELEASE TAB

Last updated on 2023-01-12 History
Report ID 172772
Drug Identification Number 02230302
Brand name CODEINE CONTIN 50MG CONTROLLED RELEASE TAB
Common or Proper name Codeine Controlled Release Tablets
Company Name PURDUE PHARMA
Market Status MARKETED
Active Ingredient(s) CODEINE
Strength(s) 50MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 60
ATC code R05DA
ATC description COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-10-27
Actual start date 2022-10-27
Estimated end date 2023-01-13
Actual end date 2023-01-11
Shortage status Resolved
Updated date 2023-01-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3381 STEELES AVENUE EAST
TORONTO, ONTARIO
CANADA M2H 3S7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2023-01-12 English Compare
v21 2023-01-11 French Compare
v20 2023-01-11 English Compare
v19 2023-01-09 French Compare
v18 2023-01-09 English Compare
v17 2022-12-21 French Compare
v16 2022-12-21 English Compare
v15 2022-12-15 French Compare
v14 2022-12-15 English Compare
v13 2022-12-09 French Compare
v12 2022-12-09 English Compare
v11 2022-12-02 French Compare
v10 2022-12-02 English Compare
v9 2022-11-28 French Compare
v8 2022-11-28 English Compare
v7 2022-11-17 French Compare
v6 2022-11-17 English Compare
v5 2022-11-07 French Compare
v4 2022-11-07 English Compare
v3 2022-10-28 English Compare

Showing 1 to 20 of 22